Southwest Oncology Group Phase II Trial (S0341) of Erlotinib (OSI-774) in Patients with Advanced Non-small Cell Lung Cancer and a Performance Status of 2
収録刊行物
-
- Journal of Thoracic Oncology
-
Journal of Thoracic Oncology 3 (9), 1026-1031, 2008-09
Elsevier BV